Metachromatic leukodystrophy is a metabolic disorder caused by the deficiency of arylsulfatase A. Deficiency of this enzyme is also found in apparently healthy individuals, a condition for which the term pseudodeficiency was introduced. The arylsulfatase A (cerebroside-3-sulfate 3-sulfohydrolase; EC 3.1.6.8) (ASA) encoding gene was isolated from an individual homozygous for the ASA pseudodeficiency allele. Sequence analysis revealed two A --G transitions. One changes Arg-350 to serine, which leads to the loss of a utilized N-glycosylation site. This loss explains the smaller size of ASA in ASA pseudodeficiency fibroblasts. The introduction of Ser-350 into normal ASA cDNA does not affect the rate of synthesis, the stability, or the catalytic properties of ASA in stably transfected baby hamster kidney cells. Therefore, the loss of the N-linked oligosaccharide does not contribute to the reduction of ASA activity in ASA pseudodeficiency. The other A -* G transition changes the first polyadenylylation signal downstream of the stop codon from AATAAC to AGTAAC. The latter causes a severe deficiency of a 2.1-kilobase (kb) mRNA species. The deficiency of the 2.1-kb RNA species provides an explanation for the diminished synthesis of ASA seen in pseudodeficiency fibroblasts. Amplification of genomic DNA and hybridization with allele-specific oligonucleotides detected both mutations in four unrelated individuals with ASA pseudodeficiency.
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Metachromatic leukodystrophy is a lysosomal storage disorder caused by the deficiency of arylsulfatase A (cerebroside-3-sulfate 3-sulfohydrolase; EC 3.1.6.8) (ASA), which leads to the intralysosomal accumulation of cerebroside sulfate (1) . The incidence of this recessively inherited disease is estimated to be 1:40,000. The sulfatide storage affects mainly the central nervous system, causing a progressive demyelination that eventually leads to the death of the patient. Based on the age of onset three clinical variants of metachromatic leukodystrophy are differentiated: late infantile,juvenile, and adult (1) . The molecular basis for this heterogeneity is not known, and the determination of the residuaL ASA activity does not permit differentiation between the various forms.
Occasionally, the deficiency of ASA is found in apparently healthy individuals, a condition known as ASA pseudodeficiency (2) . The ASA deficiency in metachromatic leukodystrophy and pseudodeficiency are caused by allelic mutations of the same gene (3) . It has been shown that the ASA synthesized in fibroblasts from individuals with ASA pseudodeficiency is reduced in quantity and smaller in size when compared to normal (4) . While the size difference has been attributed to altered glycosylation, the reasons for the attenuated ASA activity remained unclear.
The high frequency of the ASA pseudodeficiency allele of 7-15% (5, 6) and the inability to distinguish reliably homoand heterozygotes for nonfunctional and pseudodeficiency ASA alleles by ASA activity determinations with artificial or natural substrates pose serious problems in the genetic counseling and prenatal diagnosis of metachromatic leukodystrophy (7) . Thus, the availability of allele-specific tests would facilitate genetic counseling and pre-and postnatal diagnosis in families at risk for metachromatic leukodystrophy.
We show here that in the ASA pseudodeficiency allele one of two utilized N-glycosylation sites is missing. The attenuated ASA activity, however, is due to a second mutation in a polyadenylylation signal, used to generate the major poly 
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from peripheral blood cells was digested with EcoRI and four enzymes, which do not cut within the genomic 6-kb ASA fragment (Xba I, Sst I, EcoRV, and BcR I). Digested DNA was separated on 0.6% agarose gel, and the region between 5 and 7 kb was cut into seven slices (13) , which were electroeluted in 0.2 TBE (90 mM Tris/64.6 mM boric acid/2.5 mM EDTA, pH 8.3) overnight. The electroeluted material was concentrated to -300 41 in a Speedvac vacuum, extracted with phenol and chloroform, and after vacuum addition of 3 ,g of carrier tRNA precipitated overnight with ethanol at -20'C. The pellets were redissolved, and the fraction with the highest frequency of ASA DNA was determined by Southern blot hybridization. An aliquot of this fraction was ligated to AgtlO arms (Promega), packaged (Stratagene packaging extracts), and plated. Of 16,000 independent plaques, 14 hybridized with the ASA cDNA probe. One of these plaques was purified, and its 6-kb EcoRI fragment was subcloned into Bluescript. Restriction fragments of the normal and the pseudodeficiency DNA were subcloned into M13mp18 and mpl9. Regions known to code for the potential glycosylation sites and the polyadenylylation signal were sequenced by using ASA-specific oligonucleotides as primers.
Amplification of Genomic DNA and Hybridization with Allele-Specific Oligonucleotides. One microgram of genomic DNA was amplified in 100 ,u of 0.2 mM dNTP/10% dimethyl sulfoxide/50 mM KCI/10 mM Tris-HCI, pH 8.3/1.5 mM MgCI2/0.01% gelatine using the oligonucleotides ON 16 and ON 3.9 (ON 16, 5'-TTGATGGCGAACTGAGTGAC-3'; ON 3.9, 5'-TTCCTCATTCGTACCACAGG-3') as primers. After initial denaturation for 7 min at 95°C, 2.5 units of Taqpolymerase (Cetus) was added. Conditions for each of the 40 cycles were 1-min denaturation at 95°C, 1-min hybridization at 50°C, and 4-min elongation at 72°C. Final extension was 7 min. About 100 ng of amplified fragments was loaded on a 1% agarose gel, denatured, and blotted onto Hybond-N filters (Amersham). Filters were prehybridized for 2 hr at 55°C in 4 ml of 6x SSC (lx SSC is 0.15 M sodium chloride/0.015 M sodium citrate, pH 7)/0.1% SDS/0.05% sodium pyrophosphate/salmon sperm DNA at 100 ug/ml. Oligonucleotides A-D (A, 5'-AAGGTGACATTGGGCAGTGG-3'; B, 5'-AAGGTGACACTGGGCAGTGG-3'; C, 5'-CTGGTGTTAT-TACGTTATC-3'; and D, 5'-CTGGTGTTACTACGTTATC-3') were phosphorylated by using T4 polynucleotide kinase and [a-32P]ATP (specific activity > 3000 Ci/mmol). Approximately 5 x 105 cpm/ml were added and allowed to hybridize for 4 hr. Hybridization temperature for oligonucleotides A + B was 55°C, for oligonucleotides C + D it was 48°C. Filters were washed at room temperature twice for 15 min and then for 10 min in 6x SSC/0.1% SDS/0.05% sodium pyrophosphate at 62°C (oligonucleotide A), 60°C (oligonucleotide B), or 52°C (oligonucleotides C and D).
Site-Directed Mutagenesis and DNA Transfections. The normal ASA cDNA was cloned into M13mpl8, and singlestranded DNA was isolated. Site-directed mutagenesis was done as described (14) . After mutagenesis double-stranded DNA was prepared, and the EcoRI cDNA fragment was isolated and cloned into the expression vector pBEH (15) . Transfections of BHK cells were done as described (10) . Expression vectors were cotransfected with pSV2pac (16) . Two days after transfection the medium was supplemented with puromycin at 5 ,ug/ml for the selection of stably transfected cells. NH4Cl was added to induce secretion of the newly synthesized ASA into the medium (17) . The amount of 35S-labeled ASA in the medium is not affected by degradation in lysosomes and reflects, therefore, the rate of ASA synthesis more faithfully than the 35S-labeled ASA isolated from cells labeled without NH4Cl. Deoxymannojirimycin was added to prevent the processing of N-linked oligosaccharides to complex type structures (18) , thereby facilitating the complete deglycosylation of ASA by endoglucosaminidase H.
RESULTS
Normal fibroblasts secrete a 62-kDa ASA polypeptide ( Fig.  1) , whereas the ASA secreted by ASA pseudodeficiency fibroblasts is =2.5 kDa smaller. The amount of 35S-labeled ASA secreted by ASA pseudodeficient cells is only 10% compared to normal. Both media contained comparable amounts (±10%) of 35S-labeled polypeptides and of 35S-labeled cathepsin D, a lysosomal enzyme not affected in ASA pseudodeficiency (data not shown). Thus, the apparent rate of ASA synthesis is severely reduced in ASA pseudodeficiency. Digestion with endoglucosaminidase H reduced the size of the normal ASA by S kDa and that of the pseudodeficiency ASA by 2.5 kDa and produced deglycosylated polypeptides of the same size (Fig. 1) . This result indicates that normal and pseudodeficiency ASA have polypeptide backbones of the same size and differ in the number of N-linked oligosaccharides.
Loss of the Third Potential N-Glycosylation Site in the ASA Pseudodeficiency Allele. A 6-kb ASA genomic clone containing the entire ASA gene was isolated from a library made from size-selected genomic DNA of an individual homozygous for ASA pseudodeficiency allele (5) . Knowledge of the ASA cDNA sequence and of the intron-exon organization of the ASA gene (J.K., unpublished work) allowed the sequencing of the exons that contain the potential N-glycosylation sites. The N-glycosylation sites corresponding to cDNA nucleotides 472-480 and 550-558 (10) were present in the ASA pseudodeficiency allele. In the third N-glycosylation site at position 1048-1056 an A -k G transition was found at nucleotide (nt) 1049 ( Fig. 2A) , which changes Asn-350 to a serine residue and causes the loss ofthis N-glycosylation site. (Bottom) The nucleotide sequences and deduced amino acid sequences around the third N-glycosylation site (A) and in the polyadenylylation signal (B) are shown. A -* G transitions are shown in boldface letters, and the potential N-glycosylation site and the polyadenylylation signal in the normal allele are underlined. Sequencing was done with ASA-specific oligonucleotides as primers. In A the coding strand was sequenced; in B the noncoding strand was sequenced. To allow direct reading of the sequences the sequencing gel shown in B is reproduced after upside-down and frontsidebackside inversion. Both mutations were sequenced on both strands. In addition to the sequences shown here -90%o of the coding regions of the ASA pseudodeficiency gene were sequenced, and no other mutations were found.
Both cell lines contained similar copy numbers of the transfected ASA cDNA as judged by Southern blot analysis and comparable amounts of ASA activity and ASA polypeptides as judged by activity determination and Western (immunologic) blot analysis (data not shown). Only the apparent size of the ASA encoded by the mutant lacking the third potential N-glycosylation site was 2.5 kDa smaller than normal ASA. The apparent rate of ASA synthesis was analyzed by metabolic labeling of the cells in 10 mM NH4Cl. The medium contained similar amounts of labeled ASA polypeptides and ASA activity (Fig. 3) (Fig. 4) . Because the three RNA species arise from the use of different polyadenylylation signals (J.K., unpublished work), the deficiency of the 2.1-kb mRNA species may be caused by loss of the polyadenylylation signal used for its generation. Sequencing revealed an A -* G transition at a position corresponding to nt 1620 of the ASA cDNA (10) . This substitution changes the first polyadenylylation signal downstream of the termination codon from AATAAC (19) to AGTAAC (Fig.  2B) . Loss of the polyadenylylation signal associated with deficiency of the 2.1-kb mRNA species provides an explanation for the decreased synthesis of ASA in pseudodeficiency.
Deficient termination of transcription at the first polyadenylylation signal in ASA pseudodeficiency should result in increased amounts of the larger 3.7-and 4.8-kb ASA RNA species (20) ; this was not seen in the poly(A)+ (Fig. 4) . When total RNA from normal fibroblasts was assayed, the 3.7-and 4.8-kb ASA RNA species were the major RNAs hybridizing to ASA cDNA. A similar pattern was seen in RNA from four patients with metachromatic leukodystrophy, where the level of ASA RNA from one patient was severely reduced, if present at all (Fig. 5) . In total RNA the 2.1-kb ASA mRNA accounted for 30-40% of the ASA RNA. The total RNA from an individual homozygous for ASA pseudodeficiency was deficient in the 2.1-kb ASA mRNA, whereas the amount of the 3.7-and 4.8-kb ASA RNA was comparable to that in the other RNA samples. The (the ratio of the ASA RNA to actin RNA varied between 11% and 100%) did not allow a decision about whether amounts of the 3.7-and 4.8-kb ASA RNA increase in pseudodeficiency. However, these results clearly indicate that transcription of the ASA gene is not significantly altered in ASA pseudodeficiency.
Detection of the Pseudodeficiency Allele with Allele-Specific Oligonucleotides. The presence of both mutations was analyzed in four unrelated individuals with ASA pseudodeficiency. A 1.1-kb fragment encompassing the third Nglycosylation site and the polyadenylylation signal was amplified from genomic DNA. Four allele-specific oligonucleotides were hybridized to the amplified DNA. Washing conditions were chosen such that hybridization signals were seen only when all bases match (Fig. 6) . In each of the four unrelated individuals with ASA pseudodeficiency both mutations were detectable. In two obligate heterozygotes the normal and pseudodeficiency alleles were found. Figs. 4 and 5) .
DISCUSSION
ficiency is used for the generation of a 2.1-kb ASA mRNA species, which accounts for =90%o of the ASA RNA in poly(A)+ RNA of human fibroblasts. In fibroblasts from three individuals with ASA pseudodeficiency the 2.1-kb ASA mRNA was markedly deficient. The severe deficiency of the 2.1-kb ASA mRNA correlates well with diminished synthesis of ASA polypeptides and ASA activity attenuation in ASA pseudodeficiency fibroblasts.
The diminished termination at the first polyadenylylation signal codon is expected to yield increased amounts of the larger 3.7-and 4.8-kb ASA RNA species (20, 21) . Because these species represent 60-70% of the ASA RNA in total RNA and the amount of ASA RNA was variable in total RNA of the cell lines analyzed, it was not possible to evaluate whether amounts of the 3.7-and 4.8-kb ASA RNA increased by 30-40%o in total RNA from ASA pseudodeficiency fibroblasts. We conclude from normal amounts of ASA RNA in total RNA that transcription of the ASA gene is unaffected in ASA pseudodeficiency. The low recovery of the 3.7-and 4.8-kb ASA RNA species in the poly(A)+ RNA suggests that these species are poorly polyadenylylated. The attenuated synthesis of ASA polypeptides in the ASA pseudodeficiency indicates that these nonpolyadenylated species might be translationally inactive. However, whether the low amounts of the 3.7-and 4.8-kb poly(A)+ ASA RNAs can be translated or whether trace amounts of the 2.1-kb ASA RNA species found in the pseudodeficiency account for the residual ASA synthesis is presently unclear.
The four individuals with ASA pseudodeficiency that have been examined so far carried both mutations. Because the mutation affecting the N-glycosylation site is unrelated to the attenuated ASA activity in ASA pseudodeficiency, individ- uals with ASA pseudodeficiency possibly could be found that carry only the mutation in the polyadenylylation signal and express a normally glycosylated ASA due to a segregation of both mutations. Furthermore, ASA carrying only one oligosaccharide may be found in individuals with normal ASA activity.
For diagnostic purposes we have so far analyzed 31 individuals, of which 6 were homozygous and 16 were heterozygous for the pseudodeficiency allele. In none of these individuals has a segregation of the mutations occurred.
The allele-specific tests described here permit precise differentiation between ASA pseudodeficiency and ASA deficiency leading to metachromatic leukodystrophy; this distinction is particularly needed for the genetic counseling of metachromatic leukodystrophy in families in which nonfunctional and pseudodeficiency alleles for ASA occur. Furthermore, these tests allow the identification of compound heterozygotes for the pseudodeficiency and a nonfunctional ASA allele. Given the gene frequency for nonfunctional ASA Genetics: Gieselmann et al.
